Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of PA21 chewable tablets vs sevelamer carbonate in Chinese dialysis CKD patients with hyperphosphatemia
CTR20181082Phase 3Completed
- Sponsor
- Vifor Fresenius Medical Care Renal Pharma
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of iron sucrose in hyperphosphatemia, sponsored by Vifor Fresenius Medical Care Renal Pharma. Started Jul 2018; status: completed.
02
Drugs
iron sucrose
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on CTR20181082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181082.